Fact CheckerSign in

NCT05674994RecruitingPhase 3

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 2 Mar 2026

Brief summary (registry, in English)

Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is associated with a poor prognosis, with a 3-month mortality rate of over 50%. To date, no treatment has been proven to be effective in AI-FPI. The interest of glucocorticoids is controversial and needs to be confirmed. This confirmation is mandatory to validate the improvement of the prognosis of EA-IPF under this treatment but also to search for unsuspected deleterious effects as it has been shown with immunosuppressants in stable idiopathic pulmonary fibrosis.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
110 (estimated)
First submitted
9 Dec 2022
Start date
26 Oct 2023
Primary completion date
30 Mar 2026
Lead sponsor
Fondation Hôpital Saint-Joseph
NCT number
NCT05674994
EU CT number
2024-514799-42-00
EudraCT number
2022-002464-75

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 110
  • From 26 Oct 2023 to the primary completion date, 30 Mar 2026
  • 28 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient on a lung transplantation waiting list
  • Treatment with glucocorticoids \> 1 mg/kg/d from more than 7 days in the last 15 days

Other illness

  • Identified etiology for acute worsening (i.e.: infectious disease)
  • Known hypersensitivity to glucocorticoids or to any component of the study treatment
  • Active bacterial, viral, fungal or parasitic infection. On swab collected, only positive for SARS-CoV-2, Influenzae A, Influenzae B and Respiratory Syncytial Virus (RSV) result, are considered active viral infection. The others viruses (i.e. Rhinovirus, Adenovirus…) are not considered to be responsible of pneumonia.
  • Active cancer

Other

  • Patient requiring mechanical ventilation or already on mechanical ventilation
  • Patient participating to another interventional clinical trial
  • Documented pregnancy or lactation
  • Patient under tutorship or curatorship
  • Patient deprived of liberty
  • Patient under court protection

Who the study is looking for

  • Patient is ≥ 18 years of age
  • IPF or IPF (likely) diagnosis defined on 2018 international recommendations
  • Definite or suspected Acute Exacerbation defined by the international working group criteria after exclusion of alternative diagnoses of acute worsening
    • \*The criteria of IPF-AE are as follows:
    • Previous or concurrent diagnosis of IPF (a)
    • Acute worsening or development of dyspnea typically \< 1-month duration
    • Computed tomography with new bilateral ground-glass opacity and/or consolidation superimposed on a background pattern consistent with usual interstitial pneumonia pattern (b)
    • Deterioration not fully explained by cardiac failure or fluid overload Patients who fail to meet all 4 criteria due to missing computed tomography should be considered as having "suspected Acute Exacerbation".
    • If the diagnosis of IPF is not previously established, this criterion can be met by the presence of radiologic and/or histopathologic changes consistent with usual interstitial pneumonia pattern on the current evaluation.
    • If no previous computed tomography is available, the qualifier "new" can be dropped from the third criterion.
  • For women of childbearing age: efficient contraception for the duration of the study\*
    • \*Effective contraception is defined as any contraceptive method that is used consistently and appropriately and has a low failure rate (i.e., less than 1% per year)
  • Affiliation to the social security
  • Patient able to understand and sign a written informed consent form or in case of incapacity of the patient to a relative whom understand and sign a written informed consent form

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (28)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Hospitalier Universitaire D'Angers
Coordinator of this site? Confirm its status
AngersFranceRecruiting
Centre Hospitalier Regional Universitaire
Coordinator of this site? Confirm its status
Besancon CedexFranceRecruiting
Assistance Publique Hopitaux De Paris
Coordinator of this site? Confirm its status
BobignyFranceRecruiting
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
BronFranceRecruiting
Centre Hospitalier Universitaire De Caen Normandie
Coordinator of this site? Confirm its status
Caen Cedex 9FranceRecruiting
University Hospital Of Clermont-Ferrand
Coordinator of this site? Confirm its status
Clermont Ferrand Cedex 1FranceRecruiting
Centre Hospitalier Intercommunal Créteil
Coordinator of this site? Confirm its status
CréteilFranceRecruiting
Centre Hospitalier Universitaire de Dijon
Coordinator of this site? Confirm its status
DijonFranceRecruiting
Centre Hospitalier Universitaire Grenoble Alpes
Coordinator of this site? Confirm its status
Grenoble Cedex 9FranceRecruiting
Assistance Publique Hopitaux De Paris
Coordinator of this site? Confirm its status
Le Kremlin-BicetreFranceRecruiting
Centre Hospitalier Universitaire de Lille
Coordinator of this site? Confirm its status
LilleFranceRecruiting
Centre Hospitalier Regional De Marseille
Coordinator of this site? Confirm its status
MarseilleFranceRecruiting
Centre Hospitalier Universitaire De Montpellier
Coordinator of this site? Confirm its status
Montpellier Cedex 5FranceRecruiting
CHRU de Nancy
Coordinator of this site? Confirm its status
NancyFranceRecruiting
Centre Hospitalier Universitaire de Nice
Coordinator of this site? Confirm its status
NiceFranceRecruiting
Assistance Publique Hopitaux de Paris
Coordinator of this site? Confirm its status
ParisFranceRecruiting
GIE Groupe hospitalier Paris Saint-Joseph/Vinci
Coordinator of this site? Confirm its status
Paris Cedex 14FranceRecruiting
Assistance Publique Hopitaux De Paris
Coordinator of this site? Confirm its status
Paris Cedex 18FranceRecruiting
Hopital Tenon
Coordinator of this site? Confirm its status
Paris Cedex 20FranceRecruiting
Centre Hospitalier Universitaire de Bordeaux
Coordinator of this site? Confirm its status
PessacFranceRecruiting
Centre Hospitalier Universitaire Reims
Coordinator of this site? Confirm its status
ReimsFranceRecruiting
Centre Hospitalier Universitaire de Rennes
Coordinator of this site? Confirm its status
RennesFranceRecruiting
Centre Hospitalier Universitaire Rouen
Coordinator of this site? Confirm its status
Rouen CedexFranceRecruiting
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
Saint-HerblainFranceRecruiting
Les Hopitaux Universitaires De Strasbourg
Coordinator of this site? Confirm its status
Strasbourg CedexFranceRecruiting
Hospital Foch
Coordinator of this site? Confirm its status
SuresnesFranceRecruiting
Centre Hospitalier Universitaire De Toulouse
Coordinator of this site? Confirm its status
Toulouse Cedex 9FranceRecruiting
Centre Hospitalier Régional Universitaire de Tours
Coordinator of this site? Confirm its status
ToursFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.